IOVA Daniel Gordon Kirby buys $55K worth of shares
Jun 08, 2025, 10:36 AM
0.00%
What does IOVA do
Iovance Biotherapeutics, based in San Carlos, California, specializes in cell therapies for cancer, focusing on its lead product, Amtagvi, for melanoma treatment. The company employs 557 people and went public in 2008.
Daniel Gordon Kirby bought 30,000 shares of IOVA on 5 June at $1.84 per share, worth a total of $55K. They now own 30,000 IOVA shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
